Adaptive Biotechnologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Adaptive Biotechnologies 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. 

CEO
Chad Robins
CEOChad Robins
Employees
624
Employees624
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2009
Founded2009
Employees
624
Employees624

ADPT Key Statistics

Market cap
4.53B
Market cap4.53B
Price-Earnings ratio
-62.04
Price-Earnings ratio-62.04
Dividend yield
—
Dividend yield—
Average volume
2.54M
Average volume2.54M
High today
$28.27
High today$28.27
Low today
$26.54
Low today$26.54
Open price
$26.98
Open price$26.98
Volume
3.33M
Volume3.33M
52 Week high
$30.74
52 Week high$30.74
52 Week low
$12.00
52 Week low$12.00

Stock Snapshot

With a market cap of 4.53B, Adaptive Biotechnologies(ADPT) trades at $27.60. The stock has a price-to-earnings ratio of -62.04.

During the trading session on 2026-11-07, Adaptive Biotechnologies(ADPT) shares reached a daily high of $28.27 and a low of $26.54. At a current price of $27.60, the stock is +4.0% higher than the low and still -2.4% under the high.

Trading volume for Adaptive Biotechnologies(ADPT) stock has reached 3.33M, versus its average volume of 2.54M.

Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $30.74 and a low of $12.00.

Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $30.74 and a low of $12.00.

ADPT News

Simply Wall St 2d
Quarterly Sales Slip Might Change The Case For Investing In Adaptive Biotechnologies - Simply Wall St

...

Quarterly Sales Slip Might Change The Case For Investing In Adaptive Biotechnologies - Simply Wall St
Zacks 3d
Adaptive Biotechnologies Q3 Earnings and Revenues Top Estimates

Adaptive Biotechnologies (ADPT Quick QuoteADPT - Free Report) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of...

Adaptive Biotechnologies Q3 Earnings and Revenues Top Estimates

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.